Researcher
Oliver Bechter
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Regenerative medicine, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory of Experimental Oncology (Division)
Member
From7 May 2012 → Today
Projects
1 - 5 of 5
- Dissecting the heterotypic cell communication networks at the perivascular niche to detect andintercept the early metastatic processFrom1 Jan 2023 → TodayFunding: BOF - iBOF
- Multiplexed immunohistochemistry and digital pathology as the foundation for next-generation pathology in melanoma researchFrom1 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Next-generation pathology by MILAN: multiplex immunohistochemistry and advanced trainable image analysisFrom1 Jan 2020 → 31 Dec 2021Funding: IOF - technology validation in lab
- Preventing therapy-induced cancer stemnessFrom1 Oct 2019 → TodayFunding: IOF - technology concept exploration, BOF - projects
- Treating melanoma as an infectious diseaseFrom1 Sep 2018 → 31 Aug 2022Funding: Foundations, funds and other with scientific goal
Publications
1 - 10 of 81
- Clinical and genetic determinants of vitamin D receptor expression in cutaneous melanoma patients.(2024)
Authors: Laudine Janssen, Veerle Boecxstaens, Isabelle Cleynen, Dirk Vanderschueren, Katleen Vandenberghe, Oliver Bechter, Diether Lambrechts, Maria Garmyn
Pages: 125 - 133 - Biomarker and pharmacodynamic activity of the transforming growth factor-beta (TGFβ) inhibitor SAR439459 as monotherapy and in combination with cemiplimab in a phase I clinical study in patients with advanced solid tumors(2024)
Authors: Oliver Bechter
- Final analysis of phase II results with cemiplimab in metastatic basal cell carcinoma after hedgehog pathway inhibitors.(2024)
Authors: Oliver Bechter
Pages: 221 - 228 - A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma(2024)
Authors: Dennis Pedri, Ewout Landeloos, Yannick Van Herck, Katy Vandereyken, Thierry Voet, Wim Annaert, Diether Lambrechts, Veerle Boecxstaens, Joost van den Oord, Francesca Bosisio, et al.
- Tumor endothelial cell autophagy is a key vascular-immune checkpoint in melanoma(2023)
Authors: Francesca Rizzollo, Johan Van Weyenbergh, Oliver Bechter, Francesca Bosisio, Chris Marine, Diether Lambrechts, Gabriele Bergers, Patrizia Agostinis
- The CD58-CD2 axis is co-regulated with PD-L1 via CMTM6 and shapes anti-tumor immunity(2023)
Authors: Oliver Bechter, Chris Marine
Pages: 1207 - + - CD4+ T cell-induced inflammatory cell death controls immune-evasive tumours(2023)
Authors: Francesca Bosisio, Oliver Bechter, Chris Marine
Pages: 1033 - + - Role of immune checkpoint inhibitors in metastatic uveal melanoma: a single-center retrospective cohort study(2023)
Authors: Christophe Deroose, Annouschka Laenen, Dietmar Thal, Oliver Bechter, Patrick Schöffski, Paul Clement
Pages: 480 - 487 - Pharmacological induction of membrane lipid poly-unsaturation sensitizes melanoma to ROS inducers and overcomes acquired resistance to targeted therapy(2023)
Authors: Ali Talebi, Vincent de Laat, Xander Spotbeen, Jonas Dehairs, Ginevra Doglioni, David Nittner, Tania Roskams, Patrizia Agostinis, Oliver Bechter, Veerle Boecxstaens, et al.
- Multiomics and spatial mapping characterizes human CD8+T cell states in cancer(2023)
Authors: Stefan Naulaerts, Daniel Borras Morales, Julie Messiaen, Isaure Vanmeerbeek, Jenny Sprooten, Dena Panovska, Yannick Van Herck, Lendert Gelens, Tom Venken, Oliver Bechter, et al.